Beatriz Serrano holds a Medical Degree (University of Valladolid-UVa, 2004), Master degrees in Public Health (Pompeu Fabra University-UPF, 2006) and in Research Methodology in Health Sciences (Autonomous University of Barcelona-UAB, 2011), and a Medical Specialty in Preventive Medicine and Public Health (Hospital Clínic of Barcelona, 2009).

During her training in preventive medicine and public health she performed a half-year (2008) stay at WHO’s representative office in Cambodia working on surveillance of HIV disease, and a one-month stay (2009), at Manhiça’s Center for Research and Health-CISM in Mozambique (Barcelona Centre for International Health Research-CRESIB) working on research of malaria disease.

In 2011, she joined the Cancer Epidemiology Research Program (PREC) of the Catalan Institute of Oncology (ICO) as epidemiologist, and since then her work has focused on the epidemiology and prevention of human papillomavirus (HPV) infections and related diseases.

She is currently a member of the Unit of Infections and Cancer-Information and Interventions team (UNIC-I) and works in the HPV Information Center, a web-based resource led by ICO and the International Agency for Research on Cancer (IARC) that compiles, processes and disseminates published information on HPV and associated diseases for each of the 194 WHO member states, with the aim of accelerating the development and introduction of prevention strategies worldwide. She is also involved in several international projects with the objective of describing the role of HPV infection in the development of HPV-related cancers.

In 2017 she started her PhD studies. As part of her thesis project, she currently works on producing estimations of HPV-attributable fractions in HPV-related diseases, summarizing the characteristics and coverage of cervical cancer screening programs and developing tools to help countries to evaluate their HPV prevention strategies (cervical cancer screening, HPV vaccination). WHO is currently using the preliminary estimates of cervical cancer screening coverage to feed prediction models for calculating the demand of HPV tests. In addition, WHO has recently begun a consultation process with their Member States to adopt the produced screening coverage estimates as the official estimates of WHO.

In 2020 she became a member of CIBERESP (Instituto de Salud Carlos III), a network of 50 multidisciplinary research groups from different institutions and universities working in epidemiology and public health. Previously, from 2017 to 2019 she was a member of CIBERONC (Instituto de Salud Carlos III), a network devoted to translational cancer research of excellence.